Investing.com - Grifols reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Grifols announced earnings per share of €0.39 on revenue of €1.35B. Analysts polled by Investing.com anticipated EPS of €0.26 on revenue of €1.37B.
Grifols shares are down 20% from the beginning of the year, still down 26.92% from its 52 week high of €34.31 set on February 21. They are under-performing the STOXX 600 which is down 11.72% from the start of the year.
Grifols follows other major Healthcare sector earnings this month
Grifols's report follows an earnings beat by Grifols Pref on Thursday, who reported EPS of €0.39 on revenue of €1.35B, compared to forecasts EPS of €0.26 on revenue of €1.37B.
Pharma Mar had beat expectations on Thursday with third quarter EPS of €0.93 on revenue of €53.05M, compared to forecast for EPS of €0.05 on revenue of €38.53M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar